久久久久免费_精品国产乱码久久久久久久软件_欧美一区亚洲一区_国产一区二区三区高清在线观看_欧美日在线观看_成人网av

強(qiáng)生Ortho-Clinical Diagnostics     
強(qiáng)生旗下子公司 Ortho-Clinical Diagnostics， Inc. 提供優(yōu)質(zhì)的體外診斷產(chǎn)品，為全球的醫(yī)療專家提供了他們所需的用于更迅速地作出更好的治療決策的知識(shí)。該公司通過(guò)捐贈(zèng)者血液篩查和血型鑒定產(chǎn)品為全球輸血醫(yī)學(xué)界提供服務(wù)，幫助確保每位患者都能得到安全、血型匹配且適量的輸血。Ortho-Clinical Diagnostics 還為全球的臨床實(shí)驗(yàn)室提供了尖端的信息管理、測(cè)試技術(shù)、自動(dòng)化以及解釋工具，幫助他們提高運(yùn)營(yíng)效率和改善對(duì)患者的護(hù)理。

Ortho-Clinical Diagnostics, Inc., a Johnson & Johnson company, delivers the high quality in-vitro diagnostic products that give healthcare professionals around the world the knowledge they need to make better treatment decisions sooner. The company serves the global transfusion medicine community with donor screening and blood typing products to ensure every patient receives blood that's safe, the right type, and the right unit. Ortho Clinical Diagnostics also brings sophisticated information management, testing technologies, automation and interpretation tools to clinical laboratories worldwide to help them run more efficiently and improve patient care.
Ortho Clinical Diagnostics serves the transfusion medicine community and laboratories around the world. We’re a leading provider of total solutions for screening, diagnosing, monitoring and confirming diseases early, before they put lives at risk.

Headquartered in Raritan, NJ, with manufacturing operations in Rochester NY, Pompano Beach, FL and Cardiff, Wales, Ortho Clinical Diagnostics has more than 2,500 employees worldwide. We are dedicated to investing significant resources to continuously improve our products and develop solutions to address unmet medical needs.

Our single focus is to help hospitals, laboratories and blood centers worldwide deliver results that help patients experience a better quality of life.

Primary Business

The Company maintains a leadership position in two major market segments:

Transfusion Medicine

Donor Screening - development and commercialization of instrument systems and reagents that screen blood for AIDS , Hepatitis and Chagas’ Disease, aimed at ensuring the safety of the world's blood supply.

Immunohematology - Ortho Clinical Diagnostics is the worldwide leader in the marketing and development of instrumentation and reagent systems that enable blood typing, aimed at ensuring patient-donor compatibility in blood transfusions.

Clinical Laboratories

Clinical Chemistry - patented dry-slide technology and systems for use in stat and random access in-vitro diagnostic testing. The Company offers a broad menu covering basic metabolites, classical chemistries, special chemistries, proteins, toxicology and therapeutic drug monitoring tests.

Immunodiagnostics - enhanced chemiluminescence technology and systems offering immunoassay testing capabilities across menu categories of thyroid function, reproductive endocrinology, cardiology, anemia, metabolism, oncology and infectious diseases.

Ortho Clinical Diagnostics is a proud member of AdvaMed.

A History of Innovative Diagnostics Solutions

Ortho Clinical Diagnostics grew from the merger in 1997 of two Johnson & Johnson companies: Ortho Diagnostic Systems, a worldwide leader in transfusion medicine reagents and instrument systems, and Johnson & Johnson Clinical Diagnostics (formerly a division of Eastman Kodak Co. that was acquired by J&J in 1994), a worldwide leader in clinical laboratory systems. The Company's roots date back to 1937, when Johnson & Johnson established the Ortho Products Division. The division became a full and separate member of the Johnson & Johnson Family of Companies in 1974.

For nearly 70 years, Ortho Clinical Diagnostics has pioneered some of the most important technological advances in diagnostics. From early work with blood-type development to the latest advances in systems development, the Company has long provided the medical community with the means to make better medical decisions to better diagnose patients. Worldwide, health-care professionals rely on Ortho Clinical Diagnostics for innovative diagnostic solutions that enable effective diagnosis and enhance patient care.